Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 81 citing articles:

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
Rajesh T. Gandhi, Roger Bedimo, Jennifer Hoy, et al.
JAMA (2022) Vol. 329, Iss. 1, pp. 63-63
Closed Access | Times Cited: 348
Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review
Nick Pooley, Salim S. Abdool Karim, Béhazine Combadière, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 2, pp. 367-387
Open Access | Times Cited: 63
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency
Yijia Li, Manish C. Choudhary, James Regan, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 731
Open Access | Times Cited: 48
People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses
Hope R. Lapointe, Francis Mwimanzi, Peter K. Cheung, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 7, pp. 838-849
Open Access | Times Cited: 37
Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19
Kevin E. Kip, Erin K McCreary, Kevin Collins, et al.
Annals of Internal Medicine (2023) Vol. 176, Iss. 4, pp. 496-504
Open Access | Times Cited: 30
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
Jon Salmanton‐García, Francesco Marchesi, Francesca Farina, et al.
EClinicalMedicine (2024) Vol. 71, pp. 102553-102553
Open Access | Times Cited: 8
Trends in COVID-19 admissions and deaths among people living with HIV in South Africa: analysis of national surveillance data
Waasila Jassat, Caroline Mudara, Lovelyn Ozougwu, et al.
The Lancet HIV (2024) Vol. 11, Iss. 2, pp. e96-e105
Closed Access | Times Cited: 7
COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective
Jasmine R Marcelin, Audrey Pettifor, Holly Janes, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 5
Open Access | Times Cited: 33
Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US
Raynell Lang, Elizabeth Humes, Sally B. Coburn, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2236397-e2236397
Open Access | Times Cited: 33
From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era
Ganggang Miao, Zhiqiang Chen, Hengsong Cao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114208-114208
Open Access | Times Cited: 17
Immunogenicity, effectiveness and safety of SARS-CoV-2 vaccination in people living with HIV: A systematic review and meta-analysis
David Griffin, Rekha Pai Mangalore, Jennifer Hoy, et al.
AIDS (2023)
Open Access | Times Cited: 16
Immunogenicity of COVID-19 vaccines and their effect on HIV reservoir in older people with HIV
Vitaliy Matveev, Erik Z. Mihelic, Erika Benko, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107915-107915
Open Access | Times Cited: 15
Shielding the immunocompromised: COVID-19 prevention strategies for patients with primary and secondary immunodeficiencies
G. Olivieri, Donato Amodio, Emma Concetta Manno, et al.
Vaccine (2025) Vol. 51, pp. 126853-126853
Open Access
Network analysis of adverse event patterns following immunization with mRNA COVID-19 vaccines: real-world data from the European pharmacovigilance database EudraVigilance
Renato Ferreira‐da‐Silva, Mariana Lobo, Ana Margarida Pereira, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era
Erin K McCreary, Kevin E. Kip, Kevin Collins, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 10
Open Access | Times Cited: 23
Synergistic Activity of Remdesivir–Nirmatrelvir Combination on a SARS-CoV-2 In Vitro Model and a Case Report
Anna Gidari, Samuele Sabbatini, Elisabetta Schiaroli, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1577-1577
Open Access | Times Cited: 13
Correlation between CD4 T-Cell Counts and Seroconversion among COVID-19 Vaccinated Patients with HIV: A Meta-Analysis
Qian Zhou, Yihuang Liu, Furong Zeng, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 789-789
Open Access | Times Cited: 12
Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study
Dima Kabbani, Demitra M Yotis, Victor H. Ferreira, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 5
Open Access | Times Cited: 12
Booster shot of inactivated SARS‐CoV‐2 vaccine induces potent immune responses in people living with HIV
Haoting Zhan, Huixia Gao, Yongmei Liu, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 21
Immunogenicity and Safety of COVID-19 Vaccines among People Living with HIV: A Systematic Review and Meta-Analysis
Liangyu Kang, Weijing Shang, Peng Gao, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1569-1569
Open Access | Times Cited: 20
Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination
Teresa Po‐Yu Chiang, Jennifer L. Alejo, Jonathan Mitchell, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 9, pp. 2254-2260
Open Access | Times Cited: 19
People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses
Hope R. Lapointe, Francis Mwimanzi, Peter K. Cheung, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 18
Humoral and T-cell response 12 months after the first BNT162b2 vaccination in solid organ transplant recipients and controls: Kinetics, associated factors, and role of SARS-CoV-2 infection
Omid Rezahosseini, Sebastian Rask Hamm, Line Dam Heftdal, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 11
Six-month immune responses to mRNA-1273 Vaccine in cART-treated late presenter people living with HIV according to previous SARS-CoV-2 Infection
Matteo Augello, Valeria Bono, Roberta Rovito, et al.
AIDS (2023) Vol. 37, Iss. 10, pp. 1503-1517
Open Access | Times Cited: 11
Heterologous versus homologous boosting elicits qualitatively distinct, BA.5–cross-reactive T cells in transplant recipients
Elizabeth A. Thompson, Wabathi Ngecu, Laila Stoddart, et al.
JCI Insight (2023) Vol. 8, Iss. 10
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top